SecBot SecBot

PTIX

Protagenic Therapeutics, Inc.new
OTC· Pharmaceutical Preparations· Inc. DE· CIK 0001022899 Biotech & Drug Discovery
$0.4500 −0.01 (−2.17%)
Nov 16 4:00 PM ET · prev $0.4600
1 year
−79.5%
from $2.20 · Nov 18
30 days
−40.0%
from $0.7500
52-week range
$0.1280–2.27
−80% from high · low Jul 29
Avg volume 20D
1.7K
Nov 6 spike 8.5K
Short interest
12.9K
−0.3%
Days to cover
6.6
at average volume
Insider net
+$30.7K
1 buyer · 0 sellers · 12 mo
New fund stakes
0
Q4 2025 13F · 0 exits
Filing reports
3
analyzed by SecBot
SecBot read BEARISH 3 reports · 90 days
Balance 1 bearish · 1 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/3

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $30.7K at an average $0.4177. No open-market sales. Price is 8% above their cost.

  • InstitutionsMIXED

    Q4 2025: 1 added (0 new), 1 trimmed or exited.

  • Short sellersSTEADY

    Short interest −0.3% to 12.9K shares. 6.6 days to cover.

  • TrendDOWNTREND

    39% below its 50-day average.

Who's buying

13F· Q4 2025
0
new positions
0
exits
FundMoveSharesValue
BANK OF AMERICA CORP /DE/DOUBLED17$22.00
MORGAN STANLEYNEAR_EXIT2$2.00
CITIGROUP INCDOUBLED1,776$6.1K
UBS Group AGNEAR_EXIT56$192.00
BANK OF AMERICA CORP /DE/ADD8$27.00
GEODE CAPITAL MANAGEMENT, LLCADD77,296$15.1K
GEODE CAPITAL MANAGEMENT, LLCADD43,280$21.8K
UBS Group AGADD14,414$7.1K

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

Insider ledger

Form 4
$30.7K
bought · 1 insider
$0
sold · 0 insiders
+7.7%
vs their $0.4177 cost
DateInsiderTypeValue
Aug 21, 2026
ARMEN GARO H
EXEC. CHAIR & PRINCIPAL OFF
Aug 21, 2026
BUY$13.0K
Aug 20, 2026
ARMEN GARO H
EXEC. CHAIR & PRINCIPAL OFF
Aug 20, 2026
BUY$9.8K
Aug 19, 2026
ARMEN GARO H
EXEC. CHAIR & PRINCIPAL OFF
Aug 19, 2026
BUY$945.00
Aug 11, 2026
ARMEN GARO H
EXEC. CHAIR & PRINCIPAL OFF
Aug 11, 2026
BUY$710.40
Aug 6, 2026
ARMEN GARO H
EXEC. CHAIR & PRINCIPAL OFF
Aug 6, 2026
BUY$150.70
Aug 5, 2026
ARMEN GARO H
EXEC. CHAIR & PRINCIPAL OFF
Aug 5, 2026
BUY$1.3K
Jul 30, 2026
ARMEN GARO H
EXEC. CHAIR & PRINCIPAL OFF.
Jul 30, 2026
BUY$4.8K

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current QNoneNoneNo data$0.00
Next QNoneNoneNo data$0.00
Current FYNoneNoneNo data$0.00
Next FYNoneNoneNo data$0.00

Short side

FINRA· Oct 30, 2026
12,907
shares short
-0.3%
vs prior settlement
6.6
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 17, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 6, 2026 SEC
Protagenic Therapeutics issued a $250,000 promissory note to Patness LLC, bearing 1.0% simple interest, due upon the…
8-K · Impact 3/10
Nov 6, 2026 Earnings calendar
PTIX Q2 2027 Earnings Scheduled · 2026-11-06
Aug 21, 2026 Insider
ARMEN GARO H bought 20,000 shares
EXEC. CHAIR & PRINCIPAL OFF @ $0.6500 ($13.0K)
Aug 20, 2026 SEC
Protagenic Therapeutics received written FDA pre-IND feedback for its lead candidate PT00114 in generalized anxiety…
8-K · Impact 6/10
Aug 20, 2026 Insider
ARMEN GARO H bought 16,634 shares
EXEC. CHAIR & PRINCIPAL OFF @ $0.5898 ($9.8K)
Aug 19, 2026 Insider
ARMEN GARO H bought 2,700 shares
EXEC. CHAIR & PRINCIPAL OFF @ $0.3500 ($945.00)
Dec 31, 2025 Inst.
BANK OF AMERICA CORP · DOUBLED
17 shares ($22.00)

SecBot reports

3 filings · 1 bullish · 1 bearish · 1 neutral
All PTIX filing & press-release reports (3)